Obe-Cel May Expand CAR T-Cell Therapy Options in Relapsed/Refractory ALL.

Autor: DOHERTY, KYLE
Zdroj: OncologyLive. Nov2024, Vol. 25 Issue 15, p22-25. 4p.
Databáze: Academic Search Ultimate